Position
Creative Planning in Entrada Therapeutics, Inc.
Back to the book · All holders of TRDA
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $51.7K$10.28 → $12.62
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 22.1K | $227K | — | — | — | 0.0% |
| Q1 2026 | 22.2K | $280.5K | $12.62 | $51.7K | $1.87K | 0.0% |